Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$145,081,280
+$27,519,018 QoQ
Shares Held
576,543
+6.7% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#197
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$603,936
PutShares
2,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $1,542,735,587 across 15 Drug Manufacturers - General names. ABBV ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,833,813 | $465,733,487 | |
| 2 | LLY |
ELI LILLY & Co
|
183,702 | $220,337,708 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,625,531 | $208,880,733 | |
| 4 | AMGN |
Amgen Inc
|
464,220 | $168,103,346 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
576,543 | $145,081,280 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,764,695 | $101,681,725 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
603,836 | $76,288,640 | |
| 8 | PFE |
Pfizer Inc
|
3,158,575 | $76,058,486 |
All Filings in ABBV
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,081,280 | 576,543 | Shares | Sole | 2026-07-15 | |
| 2026-06-30 | $603,936 | 2,400 | Put | Sole | 2026-07-15 | |
| 2026-03-31 | $117,562,262 | 540,541 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $145,481,867 | 636,710 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $131,975,484 | 569,990 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $102,954,133 | 554,650 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $112,397,004 | 536,450 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $93,179,660 | 524,365 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $51,850 | 13,300 | Put | Sole | 2024-10-24 | |
| 2024-09-30 | $109,857,136 | 556,295 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $77,499,768 | 451,841 | Shares | Sole | 2024-07-16 | |
| 2024-06-30 | $3,740 | 400 | Put | Sole | 2024-07-16 | |
| 2024-03-31 | $1,680 | 12,000 | Put | Sole | 2024-04-15 | |
| 2024-03-31 | $77,344,789 | 424,738 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $60,749,169 | 392,006 | Shares | Sole | 2024-01-30 | |
| 2023-12-31 | $18,487 | 13,300 | Put | Sole | 2024-01-30 | |
| 2023-09-30 | $65,784,649 | 441,330 | Shares | Sole | 2023-11-13 | |
| 2023-09-30 | $45,885 | 13,300 | Put | Sole | 2023-11-13 | |
| 2023-06-30 | $3,772,440 | 28,000 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $5,085,815 | 31,912 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $5,977,310 | 44,537 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,091,706 | 13,657 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $256,944 | 1,585 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $257,530 | 1,902 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $587,675 | 5,448 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $613,324 | 5,445 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $576,379 | 5,326 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $516,677 | 4,822 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,481,702 | 39,750 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,408,220 | 34,714 | Shares | Sole | 2020-10-13 | |
| 2020-03-31 | $2,598,764 | 34,109 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||